Efficacy of Tranexamic Acid Containing Oral Medication on Melasma / 대한피부과학회지
Korean Journal of Dermatology
;
: 565-571, 2011.
Article
in Korean
| WPRIM
| ID: wpr-222371
ABSTRACT
BACKGROUND:
Melasma causes considerable cosmetic disfigurement and none of the existing treatment modalities are satisfactory. Recently tranexamic acid has been reported to reduce hyperpigmentation in patients with melasma.OBJECTIVE:
The purpose of the study was to evaluate the efficacy and safety of tranexamic acid containing oral medication for the treatment of melasma.METHODS:
Forty-five female volunteers who had been diagnosed with melasma were enrolled in the present study. Patients were instructed to take medication for 8 weeks. The melanin index (MI) and erythema index (EI) were measured at baseline, and at 4 and 8 weeks. The melasma area and severity index (MASI) was scored at 0, 4, and 8 weeks. Self-satisfaction and safety evaluations were also performed at each visit.RESULTS:
The mean MI measured on the lesional skin was decreased at 4 and 8 weeks compared with baseline (p80% of patients were satisfied with the medication. Adverse effects were minimal and two patients dropped out of the study due to drug-related urticaria and unexpected pregnancy.CONCLUSION:
Tranexamic acid-containing oral medication is an effective and safe therapeutic modality for the treatment of melasma.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Self-Assessment
/
Skin
/
Tranexamic Acid
/
Urticaria
/
Hyperpigmentation
/
Cosmetics
/
Erythema
/
Melanins
/
Melanosis
Limits:
Female
/
Humans
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS